Editorial: liver and kidney injury from remdesivir-an issue not as much as its purpose. Authors' reply

Carlos K H Wong^{1

2

3}, Ivan C H Au¹, Wing Yiu Cheng⁴, Kenneth K C Man^{1

5}, Kristy T K Lau¹, Lung Yi Mak^{6

7}, Sing Leung Lui⁸, Matthew S H Chung¹, Xi Xiong¹, Eric H Y Lau^{3

9}, Benjamin J Cowling^{3

9}

Affiliations

¹ Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
² Department of Family Medicine and Primary Care, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
³ Laboratory of Data Discovery for Health Limited (D24H), Hong Kong Science Park, Hong Kong SAR, China.
⁴ School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
⁵ Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.
⁶ Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
⁷ State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong SAR, China.
⁸ Department of Medicine, Tung Wah Hospital, Hong Kong SAR, China.
⁹ WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, Hong Kong SAR, China.

PMID: 35538354
DOI: 10.1111/apt.16932

Editorial

Editorial: liver and kidney injury from remdesivir-an issue not as much as its purpose. Authors' reply

Carlos K H Wong et al. Aliment Pharmacol Ther. 2022 Jun.

. 2022 Jun;55(11):1457-1458.

doi: 10.1111/apt.16932.

Authors

Affiliations

¹ Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
² Department of Family Medicine and Primary Care, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
³ Laboratory of Data Discovery for Health Limited (D24H), Hong Kong Science Park, Hong Kong SAR, China.
⁴ School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
⁵ Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.
⁶ Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
⁷ State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong SAR, China.
⁸ Department of Medicine, Tung Wah Hospital, Hong Kong SAR, China.
⁹ WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, Hong Kong SAR, China.

PMID: 35538354
DOI: 10.1111/apt.16932

No abstract available

PubMed Disclaimer

Comment on

Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID-19: a self-controlled case series study.
Wong CKH, Au ICH, Cheng WY, Man KKC, Lau KTK, Mak LY, Lui SL, Chung MSH, Xiong X, Lau EHY, Cowling BJ. Wong CKH, et al. Aliment Pharmacol Ther. 2022 Jul;56(1):121-130. doi: 10.1111/apt.16894. Epub 2022 Mar 22. Aliment Pharmacol Ther. 2022. PMID: 35318694 Free PMC article.
Editorial: liver and kidney injury from remdesivir-an issue not as much as its purpose.
Vuppalanchi S, Vuppalanchi R. Vuppalanchi S, et al. Aliment Pharmacol Ther. 2022 Jun;55(11):1456. doi: 10.1111/apt.16921. Aliment Pharmacol Ther. 2022. PMID: 35538355 No abstract available.

References

REFERENCES

1. Wong CK, Au IC, Cheng WY, Man KK, Lau KT, Mak LY, et al. Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID-19: a self-controlled case series study. Aliment Pharmacol Ther. 2022; DOI: 10.1111/apt.16894
1. Vuppalanchi S, Vuppalanchi R. Editorial: liver and kidney injury from Remdesivir - an issue not as much as its purpose. Aliment Pharmacol Ther. 2022;55:1456.
1. Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41(1):20-32.
1. Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, Abediazar S, Shoja MM, Ardalan M, et al. Covid-19 and kidney injury: pathophysiology and molecular mechanisms. Rev Med Virol. 2021;31(3):e2176.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Editorial: liver and kidney injury from remdesivir-an issue not as much as its purpose. Authors' reply

Affiliations

Editorial: liver and kidney injury from remdesivir-an issue not as much as its purpose. Authors' reply

Authors

Affiliations

Comment on

Similar articles

References

REFERENCES

Publication types

MeSH terms

Substances

Comment on

Similar articles

References

REFERENCES

Publication types

MeSH terms

Substances

Related information